🚀 AI-picked stocks soar in May. PRFT is +55%—in just 16 days! Don’t miss June’s top picks.Unlock full list

$18 Million Bet On This Biotechnology Stock? 4 Stocks Insiders Are Buying

Published 18/08/2022, 13:50
© Reuters.  $18 Million Bet On This Biotechnology Stock? 4 Stocks Insiders Are Buying
NSIT
-
SBGI
-
ALHF
-
GHL
-
AEI
-
CINC
-
DINO
-

Although US stocks closed lower on Wednesday following the release of Fed minutes, there were a few notable insider trades.

When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock. Insider purchases should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a buying decision.

Below is a look at a few recent notable insider purchases. For more, check out Benzinga's insider transactions platform.

CinCor Pharma

  • The Trade: CinCor Pharma, Inc. (NASDAQ: CINC) 10% owner 5AM Opportunities II, L.P. acquired a total of 600,000 shares at an average price of $30.00. To acquire these shares, it cost around $18 million.
  • What’s Happening: CinCor Pharma recently priced upsized 7.5 million share public offering of common stock and pre-funded warrants at $30 per share.
  • What CinCor Pharma Does: CinCor Pharma Inc is a clinical-stage biopharmaceutical company focused on developing its lead clinical candidate, CIN-107, for the treatment of hypertension and other cardio-renal diseases.
HF Sinclair
  • The Trade: HF Sinclair Corporation (NYSE: DINO) Director Franklin Myers acquired a total 4,800 shares at an average price of $51.98. To acquire these shares, it cost around $249.5 thousand.
  • What’s Happening: HF Sinclair recently reported better-than-expected Q2 financial results.
  • What HF Sinclair Does: HF Sinclair is an integrated petroleum refiner that owns and operates seven refineries serving the Rockies, midcontinent, Southwest, and Pacific Northwest, with a total crude oil throughput capacity of 678,000 barrels per day.
Don’t forget to check out our premarket coverage here .

Also check this: Volatility In Markets Increases Following Release Of Fed Minutes

Insight Enterprises

  • The Trade: Insight Enterprises, Inc. (NASDAQ: NSIT) 10% owner ValueAct Holdings GP LLC bought a total of 51,601 shares at an average price of $94.06. To acquire these shares, it cost around $4.85 million.
  • What’s Happening: The company recently reported Q2 results.
  • What Insight Enterprises Does: Insight Enterprises Inc is a Fortune 500 global IT provider primarily engaged in helping businesses of all sizes, large enterprises, governments, schools, and health care organizations.
Greenhill & Co
  • The Trade: Greenhill & Co., Inc. (NYSE: GHL) Chairman and CEO Scott L Bok bought a total of 110,430 shares at an average price of $8.89. The insider spent around $981.56 thousand to buy those shares.
  • What’s Happening: Greenhill & Co recently posted a Q2 loss of $1.03 per share.
  • What Greenhill Does: Greenhill & Co Inc is an independent investment bank that provides financial and strategic advice on significant domestic and cross-border mergers and acquisitions, divestitures, restructurings, financings, capital raising and other transactions to a diverse client base, including corporations, partnerships, institutions and governments globally.
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read at Benzinga

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.